US 8796320
1,3,4-Oxadiazole-2-carboxamide compound
granted A61PA61P35/00A61P43/00
Quick answer
US patent 8796320 (1,3,4-Oxadiazole-2-carboxamide compound) held by Pharmadesign, Inc. expires Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Pharmadesign, Inc.
- Grant date
- Tue Aug 05 2014 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 31 2034 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P35/00, A61P43/00